Mannose-binding lectin (+54) exon-1 gene polymorphism influence human immunodeficiency virus-1 susceptibility in North Indians

Tissue Antigens

Volumn 77, Issue 1, 2011, Pages 18-22

  Chatterjee, A ^a   Rathore, A ^a   Yamamoto, N ^b   Dhole, T N ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Human immunodeficiency virus 1 infection; Innate immunity; Mannose binding lectin; Polymorphism

Indexed keywords

MANNOSE BINDING LECTIN 2;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXON; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650034510     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01563.x     Document Type: Article

References (38)

1. O'Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet 2004: 36: 565-74.
2. Alagarasu K, Selvaraj P, Swaminathan S, Raghavan S, Narendran G, Narayanan PR. Mannose binding lectin gene variants and susceptibility to tuberculosis in HIV-1 infected patients of South India. Tuberculosis 2007: 87: 535-43.
3. Ezekowitz RA, Shi L, Fraser I, Takahashi K. The mannose-binding lectin: an infection susceptibility gene. Adv Exp Med Biol 2005: 560: 99-103.
4. Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin-a soluble pattern recognition molecule. Mol Immunol 2004: 41: 113-21.
5. Jack DL, Turner MW. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 2003: 31: 753-7.
6. Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998: 199: 327-39.
7. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000: 68: 688-93.
8. Vorup-Jensen T, Petersen SV, Hansen AG et al. Distinct pathways of mannan-binding lectin (MBL) - and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol 2000: 165: 2093-100.
9. Sørensen R, Thiel S, Jensenius JC. Mannan-binding-lectin- associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol 2005: 27: 299-319.
10. Sumiya M, Super M, Tabona P et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991: 337: 1569-70.
11. Lipscombe RJ, Sumiya M, Hill AV et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992: 1: 709-15.
12. Madsen HO, Garred P, Kurtzhals JA et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994: 40: 37-44.
13. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003: 40: 73-84.
14. Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 1989: 169: 185-96.
15. Haurum JS, Thiel S, Jones IM, Fischer PB, Laursen SB, Jensenius JC. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993: 7: 1307-13.
16. Saifuddin M, Hart ML, Gewurz H, Zhang Y, Spear GT. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 2000: 81: 949-55.
17. McNicholl JM, Lal RB, Kaslow R. Human immunodeficiency virus (HIV) infection. In: Cooper DN, ed. Encyclopedia of the Human Genome. Nature Publishing Group, 2003.
18. Vajpayee M, Kaushik S. Sreenivas V, Wig N, Seth P. CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1 infected Indian population:treatment implication. Clin Exp Immunol 2005: 141: 485.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
20. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995: 155: 3013-20.
21. Mangano A, Rocco C, Marino SM et al. Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression. J Infect Dis 2008: 198: 694-700.
22. Garred P, Madsen HO, Balslev U et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997: 349: 236-40.
23. Jüliger S, Kremsner PG, Alpers MP, Reeder JC, Kun JF. Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New Guinea. Mutat Res 2002: 505: 87-91.
24. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998: 161: 3169-75.
25. Malik S, Arias M, Di Flumeri C, Garcia LF, Schurr E. Absence of association between mannose-binding lectin gene polymorphisms and HIV-1 infection in a Colombian population. Immunogenetics 2003: 55: 49-52.
26. Mead R, Jack D, Pembrey M, Tyfield L, Turner M. Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet 1997: 349: 1669-70.
27. Lipscombe RJ, Beatty DW, Ganczakowski M et al. Mutations in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 1996: 4: 13-9.
28. Vallinoto AC, Menezes-Costa MR, Alves AE et al. Mannose-binding lectin gene polymorphism and its impact on human immunodeficiency virus 1 infection. Mol Immunol 2006: 43: 1358-62.
29. Garred P, Richter C, Andersen AB et al. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol 1997: 46: 204-8.
30. Pastinen T, Liitsola K, Niini P, Salminen M, Syvänen AC. Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population. AIDS Res Hum Retroviruses 1998: 14: 695-8.
31. Boniotto M, Braida L, Pirulli D, Arraes L, Amoroso A, Crovella S. MBL2 polymorphisms are involved in HIV-1 infection in Brazilian perinatally infected children. AIDS 2003: 17: 779-80.
32. Singh KK, Lieser A, Ruan PK, Fenton T, Spector SA. An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children. J Allergy Clin Immunol 2008: 122: 173-80.
33. Catano G, Agan BK, Kulkarni H et al. Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. J Infect Dis 2008: 198: 72-80.
34. Amoroso A, Berrino M, Boniotto M et al. Polymorphism at codon 54 of mannose-binding protein gene influences AIDS progression but not HIV infection in exposed children. AIDS 1999: 13: 863-4.
35. Garcia-Laorden MI, Pena MJ, Caminero JA et al. Influence of mannose-binding lectin on HIV infection and tuberculosis in a Western-European population. Mol Immunol 2006: 43: 2143-50.
36. Maas J, De Roda Husman AM, Brouwer M et al. Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study AIDS 1998: 12: 2275-80.
37. Mombo LE, Lu CY, Ossari S et al. Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections. Genes Immun 2003: 4: 362-7.
38. Tan Y, Liu L, Luo P et al. Association between mannose-binding lectin and HIV infection and progression in a Chinese population. Mol Immunol 2009: 47: 632-8.